ACE inhibitor: Younger patients (age 22-51) respond best to angiotensin converting enzyme (ace) inhibitors or angiotensin-ii receptor blockers (arbs) and beta blockers. However, beta blockers are not commonly used for initial monotherapy without a specific indication, as they appear to provide inferior protection against stroke risk.
Answered 6/23/2014
5.3k views
3 doctors weighed in across 2 answers
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question